This is such a young company and in this climate where collection processes have been pushed to the side due to the pandemic they have still grown and they are still attracting a great amount of interest in their product not only from local organisations but also internationally. Once companies realise that they will have to start calling up outstanding debts the attitude should swing very favorably to the CCR method.
This is an ideal time to top up even further and sit back for the next two to three years and enjoy the ride.
- Forums
- ASX - By Stock
- CCR
- Ann: Trading halt
Ann: Trading halt, page-40
Featured News
Add CCR (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
0.005(1.45%) |
Mkt cap ! $144.0M |
Open | High | Low | Value | Volume |
34.0¢ | 35.0¢ | 34.0¢ | $50.32K | 146.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 18475 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 222946 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15560 | 0.345 |
10 | 38583 | 0.340 |
1 | 8346 | 0.335 |
1 | 9687 | 0.315 |
1 | 10000 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 222946 | 3 |
0.355 | 161105 | 2 |
0.365 | 24936 | 3 |
0.375 | 50000 | 1 |
0.380 | 28985 | 1 |
Last trade - 13.49pm 15/11/2024 (20 minute delay) ? |
Featured News
CCR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online